PEGASUS-TIMI 54 SUB-ANALYSIS OUTLINES LONG-TERM TOLERABILITY DATA FOR BRILIQUE
Data presented at AHA suggests benefit in patients who stayed on Brilique (ticagrelor) treatment.
Data presented at AHA suggests benefit in patients who stayed on Brilique (ticagrelor) treatment.